Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation

NCT01120366 is registered in ClinicalTrials.gov with SURPRISE Study Group as lead sponsor.

NCT NCT01120366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01120366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation
Lead sponsor
SURPRISE Study Group
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2014
Enrollment
233 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis